ProCE Banner Activity

Feasibility of Long-Acting Combination HIV and Pregnancy Prevention Implant Demonstrated in Mouse Model

Slideset Download
Conference Coverage
Implant sustained release of ARV above viral replication inhibition thresholds in a mouse model; no difference in ARV release when coformulated with either of 2 contraceptives.

Released: February 18, 2022

Expiration: February 17, 2023

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare